GT Biopharma Inc. (GTBP) stock surged during pre-market trading. Here’s to know why?
GT Biopharma Inc. (NASDAQ: GTBP) stock declined by 4.36% at the last close whereas the GTBP stock price gains by 6.81% in the pre-market trading session. GT Biopharma is a clinical-stage pharmaceutical business specializing in the discovery and marketing of immuno-oncology therapeutics based on its unique TriKE NK cell engager technology. GTBP’s TriKE platform is […]
